“The predominance of AJP in this top 10 list reinforces our emphasis on choosing landmark studies that will advance the clinical practice of psychiatry, as well as those that will provide direction for future research,” AJP Editor-in-Chief Robert Freedman, M.D., told Psychiatric News.
Two of the AJP studies selected for inclusion focused on promising new treatments for psychiatric disorders: Helen Lavretsky, M.D., and colleagues found that combining the antidepressant citalopram with methylphenidate, a stimulant, appears to improve outcomes in geriatric patients with depression; and an article by John Kane, M.D., and colleagues outlined a multifaceted treatment approach to first-episode psychosis that improves functional and clinical outcomes.
The other two AJP studies named in the top 10 list aim to improve clinical assessment: A study by Terrie Moffitt, M.D., and colleagues revealed that adults with attention-deficit/hyperactivity disorder (ADHD) do not share all the characteristics of childhood ADHD and that many adults with ADHD do not have a history of the childhood disorder; and Richard Wesseloo, M.D., and colleagues found patients with bipolar disorder were significantly less likely to experience severe episodes postpartum than patients with a history of postpartum psychosis.
Among other articles in the top 10 list were reports on the use of omega-3 fatty acids in the prevention of psychosis, bilateral transcranial magnetic stimulation for treatment of schizophrenia, the deleterious effects of marijuana use on symptoms of posttraumatic stress disorder, and the safety of SSRIs in pregnancy.
For more information, see the Psychiatric News articles “Psychosocial Treatments Found Effective for Early Psychosis” and “Study Suggests ADHD in Adults May Be Distinct Disorder.”